日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients

针对转移性乳腺癌患者，制定以患者为中心的核心结局指标集，用于评估其健康相关生活质量。

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-022-06827-6
de Ligt, K M; de Rooij, B H; Hedayati, E; Karsten, M M; Smaardijk, V R; Velting, M; Saunders, C; Travado, L; Cardoso, F; Lopez, E; Carney, N; Wengström, Y; Ives, A; Velikova, G; Sousa Fialho, M D L; Seidler, Y; Stamm, T A; Koppert, L B; van de Poll-Franse, L V
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Breast cancer patients' most important quality of life themes for a radiotherapy decision aid

乳腺癌患者在放射治疗决策辅助工具中最重要的生活质量主题

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2022.06.002
Roumen, Cheryl; Hasannejadasl, Hajar; Swart, Rachelle; Raphael, Daniela; Wee, Leonard; Sloep, Matthijs; van den Bongard, Desiree H J G; Verkooijen, Helena; Thijssen, Salina; Velting, Mirjam; Schuurman, Maaike; Russell, Nicola S; Fijten, Rianne; Boersma, Liesbeth J
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Mind your words: Oncologists' communication that potentially harms patients with advanced cancer: A survey on patient perspectives

注意言辞：肿瘤科医生可能对晚期癌症患者造成伤害的沟通方式：一项关于患者观点的调查

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.34018
Westendorp, Janine; Evers, Andrea W M; Stouthard, Jacqueline M L; Budding, Janneke; van der Wall, Elsken; Plum, Nicole M F; Velting, Mirjam; Francke, Anneke L; van Dulmen, Sandra; Olde Hartman, Tim C; Van Vliet, Liesbeth M
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Supporting Shared Decision-making About Surveillance After Breast Cancer With Personalized Recurrence Risk Calculations: Development of a Patient Decision Aid Using the International Patient Decision AIDS Standards Development Process in Combination With a Mixed Methods Design

利用个性化复发风险计算支持乳腺癌术后监测的共同决策：结合国际患者决策辅助工具标准开发流程和混合方法设计开发患者决策辅助工具

期刊:JMIR Cancer
影响因子:2.7
doi:10.2196/38088
Ankersmid, Jet Wies; Siesling, Sabine; Strobbe, Luc J A; Meulepas, Johanna M; van Riet, Yvonne E A; Engels, Noel; Prick, Janine C M; The, Regina; Takahashi, Asako; Velting, Mirjam; van Uden-Kraan, Cornelia F; Drossaert, Constance H C
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Cognitive Efficacy (SIB) of 13.3 Versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer's Disease

重度阿尔茨海默病患者使用利伐斯的明贴剂（13.3 mg/24 h）的认知疗效（SIB）与使用利伐斯的明贴剂（4.6 mg/24 h）的认知疗效比较

期刊:
影响因子:
doi:10.1177/1533317515603687
Isaacson, Richard S; Ferris, Steven; Velting, Drew M; Meng, Xiangyi
阿尔茨海默症
神经科学
发表日期：2016
文献求助 收藏

A practical algorithm for managing Alzheimer's disease: what, when, and why?

阿尔茨海默病管理的实用算法：什么、何时以及为什么？

期刊:Annals of Clinical and Translational Neurology
影响因子:3.9
doi:10.1002/acn3.166
Cummings, Jeffrey L; Isaacson, Richard S; Schmitt, Frederick A; Velting, Drew M
阿尔茨海默症
发表日期：2015
文献求助 收藏

Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease

利伐斯的明贴剂13.3 mg/24 h与4.6 mg/24 h对重度阿尔茨海默病患者日常生活活动能力的影响

期刊:SAGE Open Medicine
影响因子:2.1
doi:10.1177/2050312114561569
Micca, Joseph L; Galvin, James E; Velting, Drew M; Meng, Xiangyi
阿尔茨海默症
发表日期：2014
文献求助 收藏